Advertisement
CLDX vs HIND
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a StrongBuy and HIND is a Hold.
CLDX's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for CLDX turned positive on October 19, 2026. Looking at past instances where CLDX's MACD turned positive, the stock continued to rise in 36 of 46 cases over the following month. The odds of a continued upward trend are 78%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CLDX's RSI Oscillator exited the oversold zone, 25 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 59 cases where CLDX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
Following a +10.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLDX advanced for three days, in 206 of 267 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
CLDX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLDX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for CLDX entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. CLDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.184) is normal, around the industry mean (2.973). P/E Ratio (-6.660) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. CLDX's P/S Ratio (10000.000) is very high in comparison to the industry average of (438.009).
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLDX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
HIND in +3.00% Uptrend, rising for three consecutive days on October 09, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where HIND advanced for three days, in 142 of 174 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where HIND's RSI Oscillator exited the oversold zone, 33 of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
HIND may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HIND as a result. In 85 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for HIND turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 39 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIND declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for HIND entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.135) is normal, around the industry mean (2.988). P/E Ratio (-1.142) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (108.696) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 78 (best 1 - 100 worst), indicating slightly worse than average price growth. HIND’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIND’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
CLDX | HIND | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 62 | 88 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 98 Overvalued | 66 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 100 | |
PRICE GROWTH RATING 1..100 | 64 | 78 | |
P/E GROWTH RATING 1..100 | 22 | 25 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HIND's Valuation (66) in the null industry is in the same range as CLDX (98) in the Biotechnology industry. This means that HIND’s stock grew similarly to CLDX’s over the last 12 months.
HIND's Profit vs Risk Rating (100) in the null industry is in the same range as CLDX (100) in the Biotechnology industry. This means that HIND’s stock grew similarly to CLDX’s over the last 12 months.
CLDX's SMR Rating (98) in the Biotechnology industry is in the same range as HIND (100) in the null industry. This means that CLDX’s stock grew similarly to HIND’s over the last 12 months.
CLDX's Price Growth Rating (64) in the Biotechnology industry is in the same range as HIND (78) in the null industry. This means that CLDX’s stock grew similarly to HIND’s over the last 12 months.
CLDX's P/E Growth Rating (22) in the Biotechnology industry is in the same range as HIND (25) in the null industry. This means that CLDX’s stock grew similarly to HIND’s over the last 12 months.
| CLDX | HIND | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 74% | 4 days ago 79% |
| Stochastic ODDS (%) | 1 day ago 76% | 2 days ago 78% |
| Momentum ODDS (%) | N/A | 2 days ago 90% |
| MACD ODDS (%) | 1 day ago 78% | 2 days ago 89% |
| TrendWeek ODDS (%) | 1 day ago 79% | 2 days ago 90% |
| TrendMonth ODDS (%) | 1 day ago 79% | 2 days ago 90% |
| Advances ODDS (%) | 3 days ago 77% | 14 days ago 82% |
| Declines ODDS (%) | 1 day ago 78% | 4 days ago 90% |
| BollingerBands ODDS (%) | 1 day ago 71% | 7 days ago 81% |
| Aroon ODDS (%) | 1 day ago 83% | 2 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CLDX’s FA Score shows that 1 FA rating(s) are green while HIND’s FA Score has 1 green FA rating(s).
- CLDX’s FA Score: 1 green, 4 red.
- HIND’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CLDX’s TA Score shows that 5 TA indicator(s) are bullish while HIND’s TA Score has 4 bullish TA indicator(s).
- CLDX’s TA Score: 5 bullish, 2 bearish.
- HIND’s TA Score: 4 bullish, 4 bearish.
Price Growth
CLDX (@Biotechnology) experienced а +0.14% price change this week, while HIND (@Biotechnology) price change was -3.16% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.17%. For the same industry, the average monthly price growth was -18.21%, and the average quarterly price growth was -15.24%.
Reported Earning Dates
CLDX is expected to report earnings on Nov 09, 2026.
HIND is expected to report earnings on Nov 13, 2026.
Industries' Descriptions
@Biotechnology (-1.17% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
CLDX and
Correlation & Price change
A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with STOK. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then STOK could also see price increases.
| Ticker / NAME | Correlation To CLDX | 1D Price Change % | ||
|---|---|---|---|---|
| CLDX | 100% | -1.36% | ||
| STOK - CLDX | 49% Loosely correlated | +0.08% | ||
| VYGR - CLDX | 47% Loosely correlated | -7.92% | ||
| BCAX - CLDX | 47% Loosely correlated | -1.68% | ||
| MGTX - CLDX | 46% Loosely correlated | -0.91% | ||
| LXEO - CLDX | 46% Loosely correlated | -3.67% | ||
More | ||||
HIND and
Correlation & Price change
A.I.dvisor indicates that over the last year, HIND has been loosely correlated with IMMP. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if HIND jumps, then IMMP could also see price increases.
| Ticker / NAME | Correlation To HIND | 1D Price Change % | ||
|---|---|---|---|---|
| HIND | 100% | N/A | ||
| IMMP - HIND | 36% Loosely correlated | +0.61% | ||
| CLDX - HIND | 30% Poorly correlated | -3.04% | ||
| PHAT - HIND | 30% Poorly correlated | -3.83% | ||
| HURA - HIND | 30% Poorly correlated | +18.47% | ||
| KPTI - HIND | 29% Poorly correlated | +18.35% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DOCK | 25.95 | 0.27 | +1.04% |
| Corgi Ports, Rail & Freight ETF (DOCK) | |||
| BNDS | 47.07 | -0.10 | -0.22% |
| Infrastructure Capital Bond Income ETF | |||
| RNRG | 31.39 | -0.29 | -0.92% |
| Global X Renewable Energy Producers ETF (RNRG) | |||
| CHPY | 57.36 | -3.87 | -6.32% |
| YieldMax Semiconductor Portfolio Option Income ETF (CHPY) | |||
| EUV | 20.08 | -1.99 | -9.02% |
| Corgi Lithography & Semiconductor Photonics ETF (EUV) | |||